Anna Perri

1.6k total citations
73 papers, 1.2k citations indexed

About

Anna Perri is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Anna Perri has authored 73 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Surgery. Recurrent topics in Anna Perri's work include Thyroid Disorders and Treatments (14 papers), Thyroid Cancer Diagnosis and Treatment (9 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Anna Perri is often cited by papers focused on Thyroid Disorders and Treatments (14 papers), Thyroid Cancer Diagnosis and Treatment (9 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Anna Perri collaborates with scholars based in Italy, United States and Slovenia. Anna Perri's co-authors include Luca Chiovato, Patrizia Agretti, Massimo Tonacchera, Paolo Vitti, Danilo Lofaro, Renzo Bonofiglio, Aldo Pinchera, Donatella Vizza, Antonella La Russa and Francesca Leone and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Anna Perri

70 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Perri Italy 19 483 440 157 157 136 73 1.2k
Niina Sandholm Finland 20 305 0.6× 327 0.7× 170 1.1× 248 1.6× 203 1.5× 57 1.1k
Jong Ryeal Hahm South Korea 20 470 1.0× 343 0.8× 192 1.2× 87 0.6× 183 1.3× 74 1.1k
Sung-Hee Ihm South Korea 19 314 0.7× 362 0.8× 120 0.8× 138 0.9× 247 1.8× 61 1.0k
Shengyu Mu United States 15 287 0.6× 354 0.8× 65 0.4× 70 0.4× 177 1.3× 39 1.1k
Mengyin Cai China 15 409 0.8× 399 0.9× 199 1.3× 229 1.5× 284 2.1× 43 1.1k
Scott M. Gordon United States 22 633 1.3× 424 1.0× 165 1.1× 77 0.5× 560 4.1× 51 1.4k
Chao‐Sheng Lo Canada 18 251 0.5× 424 1.0× 54 0.3× 57 0.4× 119 0.9× 34 875
Derya Koçer Türkiye 14 303 0.6× 140 0.3× 187 1.2× 49 0.3× 138 1.0× 39 883
B. M. Frey Switzerland 22 256 0.5× 238 0.5× 77 0.5× 85 0.5× 95 0.7× 44 1.0k
Ferdinand Molnár Finland 21 190 0.4× 395 0.9× 98 0.6× 341 2.2× 57 0.4× 49 1.4k

Countries citing papers authored by Anna Perri

Since Specialization
Citations

This map shows the geographic impact of Anna Perri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Perri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Perri more than expected).

Fields of papers citing papers by Anna Perri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Perri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Perri. The network helps show where Anna Perri may publish in the future.

Co-authorship network of co-authors of Anna Perri

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Perri. A scholar is included among the top collaborators of Anna Perri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Perri. Anna Perri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seminara, Giuseppe, Mario Molinaro, G. Antonucci, et al.. (2025). Identification of Novel Genetic Variants in a Cohort of Congenital Hypogonadotropic Hypogonadism: Computational Analysis of Pathogenicity Predictions. International Journal of Molecular Sciences. 26(11). 5207–5207.
2.
Ruffolo, Silvestro Antonio, et al.. (2025). Endocrine Toxicity of Micro- and Nanoplastics, and Advances in Detection Techniques for Human Tissues: A Comprehensive Review. Endocrines. 6(2). 23–23. 4 indexed citations
3.
Bossio, Sabrina, Anna Perri, Francesco Conforti, et al.. (2024). Prostate Cancer: Emerging Modifiable Risk Factors and Therapeutic Strategies in the Management of Advanced Cancer. Life. 14(9). 1094–1094. 1 indexed citations
4.
5.
Bossio, Sabrina, Ida Perrotta, Danilo Lofaro, et al.. (2024). The Missense Variant in the Signal Peptide of α-GLA Gene, c.13 A/G, Promotes Endoplasmic Reticular Stress and the Related Pathway’s Activation. Genes. 15(7). 947–947. 2 indexed citations
6.
Lofaro, Danilo, Daniele Amparore, Anna Perri, et al.. (2024). Comparing Perioperative Complications of Off-Clamp versus On-Clamp Partial Nephrectomy for Renal Cancer Using a Novel Energy Balancing Weights Method. Life. 14(4). 442–442. 1 indexed citations
7.
8.
Rago, Vittoria, Francesco Conforti, Daniele La Russa, et al.. (2024). The Effects of Caloric Restriction on Inflammatory Targets in the Prostates of Aged Rats. International Journal of Molecular Sciences. 25(10). 5236–5236. 2 indexed citations
9.
10.
Russa, Antonella La, Danilo Lofaro, Alberto Montesanto, et al.. (2023). Association between NLRP3 rs10754558 and CARD8 rs2043211 Variants and Susceptibility to Chronic Kidney Disease. International Journal of Molecular Sciences. 24(4). 4184–4184. 6 indexed citations
11.
Rago, Vittoria, et al.. (2023). New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer. Life. 14(1). 52–52. 2 indexed citations
12.
Perri, Anna, Vittoria Rago, Daniele La Russa, et al.. (2023). Alpha-Lipoic Acid Reduces Cell Growth, Inhibits Autophagy, and Counteracts Prostate Cancer Cell Migration and Invasion: Evidence from In Vitro Studies. International Journal of Molecular Sciences. 24(23). 17111–17111. 7 indexed citations
13.
Perri, Anna, Danilo Lofaro, Lorenza Maltese, et al.. (2022). Different Expression Patterns of Metabolic Reprogramming Proteins in Testicular Germ Cell Cancer. SHILAP Revista de lepidopterología. 3(4). 578–589. 3 indexed citations
14.
Perri, Anna, Danilo Lofaro, Sabrina Bossio, et al.. (2022). Effects of One-Shot Hyaluronic Acid Injection in Lifelong Premature Ejaculation: A Pilot Study. SHILAP Revista de lepidopterología. 3(3). 538–544. 1 indexed citations
15.
Perri, Anna, Vittoria Rago, Rocco Malivindi, et al.. (2021). Overexpression of p75NTR in Human Seminoma: A New Biomarker?. Life. 11(7). 629–629. 5 indexed citations
16.
Perri, Anna, Giulia Izzo, Danilo Lofaro, et al.. (2020). Erectile Dysfunction after Kidney Transplantation. Journal of Clinical Medicine. 9(6). 1991–1991. 15 indexed citations
17.
Crafa, Andrea, Rosita A. Condorelli, Laura M. Mongioì, et al.. (2020). Mean Platelet Volume as a Marker of Vasculogenic Erectile Dysfunction and Future Cardiovascular Risk. Journal of Clinical Medicine. 9(8). 2513–2513. 13 indexed citations
18.
Santoro, Domenico, Antonella La Russa, Anna Perri, et al.. (2020). Identification of a New Complement Factor H Mutation in a Patient With Pregnancy-Related Acute Kidney Injury. Kidney International Reports. 5(9). 1603–1607.
19.
Perri, Anna, Danilo Lofaro, Giulia Izzo, et al.. (2019). The Risky Health Behaviours of Male Adolescents in the Southern Italian Region: Implications for Sexual and Reproductive Disease. Journal of Clinical Medicine. 8(9). 1414–1414. 4 indexed citations
20.
Vigna, Ernesto, Annamaria Petrungaro, Anna Perri, et al.. (2018). Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapies. Transfusion and Apheresis Science. 57(2). 247–249. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niina Sandholm Breakdown of academic impact, for papers by Jong Ryeal Hahm Breakdown of academic impact, for papers by Sung-Hee Ihm Breakdown of academic impact, for papers by Shengyu Mu Breakdown of academic impact, for papers by Mengyin Cai Breakdown of academic impact, for papers by Scott M. Gordon Breakdown of academic impact, for papers by Chao‐Sheng Lo Breakdown of academic impact, for papers by Derya Koçer Breakdown of academic impact, for papers by B. M. Frey Breakdown of academic impact, for papers by Ferdinand Molnár
Rankless by CCL
2026